[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619444":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":23,"locations":7,"responsibleParty":31,"collaborators":33,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":41,"sex":47,"minAge":48,"maxAge":48,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":57,"overallStatus":61,"whyStopped":7,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":7},{"fullName":5,"class":6},"Marche Region Regional Health Agency","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Screening program","The intervention will consist in a systematic screening of the participants to identify people at risk of developing T2DM (FINDRISC questionnaire) and CVDs (CUORE questionnaire, along with HbA1c).",[13,17,21],{"name":14,"affiliation":15,"role":16},"Claudio CA Angelini","Local Health Authority of Ascoli Piceno","PRINCIPAL_INVESTIGATOR",{"name":18,"affiliation":19,"role":20},"Roberta RP Papa","Regional Health Agency of Marche Region","STUDY_DIRECTOR",{"name":22,"affiliation":19,"role":20},"Giulia GF Franceschini",[24,28],{"name":14,"role":25,"phone":26,"phoneExt":7,"email":27},"CONTACT","+39 0736-358016","claudio.angelini@sanita.marche.it",{"name":29,"role":25,"phone":7,"phoneExt":7,"email":30},"Aurora AL Luciani","aurora.luciani@sanita.marche.it",{"type":32,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR",[34,37],{"name":35,"class":36},"REGIONAL HEALTH UNIT - MARCHE REGION - AREA 5 (ASUR Marche, Area Vasta 5, Distretto Sanitario San Benedetto), Italy","UNKNOWN",{"name":38,"class":36},"Azienda Sanitaria Locale USL 13 Ospedale Mazzoni di Ascoli Piceno","100619444","screening-for-change-early-risk-detection-and-integrated-prevention-for-diabetes-and-cardiovascular-diseases-in-the-marche-region-100619444",false,"NCT07344701","\"Screening for Change: Early Risk Detection and Integrated Prevention for Diabetes and Cardiovascular Diseases in the Marche Region\"","Early Risk Detection of Type 2 Diabetes and Cardiovascular Diseases: an Italian Cohort Study","JAC_AST","Inclusion Criteria:\n\n* Citizens resident in Ascoli Piceno province\n* People turning 50 in 2026\n* Capacity to consent\n* Fulfilling and signing the informed consent related to the participation to the study.\n\nExclusion Criteria:\n\n* a concomitant diagnosis of DM and a previous CVD major event (one or more between Myocardial infarction, Haemorrhagic and\u002For ischaemic stroke, Revascularization interventions, as percutaneous coronary intervention\u002Fcoronary artery bypass graft)\n* Failure to meet the inclusion criteria\n* Lack of written informed consent.","ALL","50 Years",{"count":50,"type":51},3000,"ESTIMATED","OBSERVATIONAL","This study aims to test the feasibility of a new systematic screening program to allow the early detection of individuals aged 50 years at risk of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVDs) in the resident in the province of Ascoli Piceno and without previous diagnosis, using the CUORE and FINDRISDC tools developed in the Project.\n\nThe intervention will be conducted at the premises of the Prevention Department in Ascoli Piceno and San Benedetto del Tronto, within the Local Health Authority of Ascoli Piceno (Marche Region, Italy), throughout 2026.\n\nEligible individuals will be invited, based on recruitment criteria, to the screening via a letter containing study information and participation instructions. Those willing to participate will book the appointment to undergo the screening in one of the two premises of the Prevention Department involved in the study (namely, San Benedetto del Tronto and Ascoli Piceno), through the regional reservation system (CUP). On the scheduled date, participants will visit the Prevention Department, where healthcare professionals (HCPs) will explain the study, obtain the informed consent, and collect data related to the CUORE and\u002For FINDRISC questionnaires, as well as sociodemographic information. The calculated scores will determine the 10-year risks of T2DM and major CVD events. Based on these risks, participants will be provided with tailored suggested pathways. A summary letter outlining these pathways will be delivered, and, in case of consent, results will be added to the participants' Electronic Health Record. Follow-up calls will be scheduled at 3 (T1) and 6 (T2) months to assess adherence to the suggested pathway (e.g., visit the General Practitioner (GP), lifestyle counselling) through a phone call.",[55,56],"Cardiovascular Diseases","Diabetes Mellitus Type 2",[58,59,60,56,55],"Diagnostic Screening Program","Delivering of healthcare, integrated","risk factors","NOT_YET_RECRUITING","2026-01-15",{"date":64,"type":65},"2026-01-20","ACTUAL",{"date":67,"type":51},"2026-01",{"date":69,"type":51},"2026-12-31",{"name":5,"class":6}]